Cardiff Oncology Inc
NASDAQ:CRDF
Cardiff Oncology Inc
NASDAQ:CRDF
Price:
1.71
USD
-1.16%
Market Closed
Market Cap:
$116.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
US |
|
Novozymes A/S
CSE:NZYM B
|
DK |
Shareholder Yield
Current shareholder yield for CRDF is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
CRDF Price
Cardiff Oncology Inc
Cardiff Oncology Inc
Annual Price Range
1.71
52w Low
1.48
52w High
4.45
Price Metrics
| Average Annual Return | 17.99% |
| Standard Deviation of Annual Returns | 111.9% |
| Max Drawdown | -90% |
Shares Statistics
| Market Capitalization | 116.8m USD |
| Shares Outstanding | 68 360 000 |
| Percentage of Shares Shorted | 27.5% |
CRDF Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
CRDF's latest stock split occurred on Feb 20, 2019
The company executed a 1-for-6 stock split, meaning that for every 6 shares held, investors received 1 new share.
Before the split, CRDF traded at 0.48 per share. Afterward, the share price was about 2.89.
The adjusted shares began trading on Feb 20, 2019. This was stock split number 4 in CRDF's history, following the previous one in Jun 4, 2018.
Pre-Split Price
2.88
0.48
Post-Split Price
2.89
Before
After
